Budesonide Oral Capsule, Gastro-Resistant Pellets 3Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Budesonide: Oral capsule, gastro-resistant pellets (3mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_14141.JPG
Budesonide 3mg Capsule
Par Pharmaceuticals, an Endo Company
Pill Identification: ENTOCORT EC 3mg 
Drug Image file DrugItem_26729.JPG
Budesonide 3mg Capsule
Mylan Pharmaceuticals Inc.
Pill Identification: MYLAN 7155 MYLAN 7155 
Drug Image file DrugItem_21760.JPG
Budesonide 3mg Capsule
Teva Pharmaceuticals USA
Pill Identification: TEVA 7445 
Drug Image file DrugItem_25142.JPG
Budesonide 3mg Capsule
Mayne Pharma
Pill Identification: LOGO 0495 LOGO 0495 

What is this Medicine?

BUDESONIDE (bue DES oh nide) is a corticosteroid. It is used in the treatment of Crohn's disease and ulcerative colitis which are types of inflammatory bowel disease.

CVS Pharmacy Patient Statistics for Budesonide: Oral capsule, gastro-resistant pellets(3mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Budesonide 3mg Capsule

NDC: 498840501
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Crohn's Disease

Sometimes used for but not FDA approved for the following conditions:
Colitis

Storage Information
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Budesonide 3mg Capsule
Drug Image file DrugItem_14141.JPG
Par Pharmaceuticals, an Endo Company
Pill Identification: ENTOCORT EC 3mg 
Shape: capsule
Color: gray,pink

Reported Side Effects for Budesonide 3mg Capsule

Eosinophilia Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Shaking Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
Hives Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
Balance Problems Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
Cataracts Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Intestinal Blockage Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
Anaphylactoid Reactions Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Causing To Be Hungry Incidence:
<5.0%*
Severity: MILD
Onset: DELAYED
Weakness Incidence:
<5.0%*
Severity: MILD
Onset: DELAYED
Breathing Difficulties Incidence:
<2.0%*
Severity: SEVERE
Onset: RAPID
Chest Pain Incidence:
<5.0%*
Severity: MODERATE
Onset: EARLY
Confusion Incidence:
<5.0%*
Severity: MODERATE
Onset: EARLY
Diaphoresis Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
Inflamed Tongue Incidence:
<5.0%*
Severity: MODERATE
Onset: EARLY
Hyperkinesis Incidence:
<5.0%*
Severity: MILD
Onset: DELAYED
Feeling Sick Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
Rapid Heart Rate Incidence:
<5.0%*
Severity: MODERATE
Onset: EARLY
Paresthesias Incidence:
<5.0%*
Severity: MILD
Onset: DELAYED
Skin Rash Incidence:
<4.0%*
Severity: MILD
Onset: EARLY
Rapid Heart Rate Incidence:
<5.0%*
Severity: MODERATE
Onset: RAPID
Visual Impairment Incidence:
<5.0%*
Severity: SEVERE
Onset: EARLY
Stomach Abnormality Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
High Blood Pressure Incidence:
<5.0%*
Severity: MODERATE
Onset: EARLY
Allergic Skin Reaction Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Cushing's Syndrome Incidence:
<11.0%*
Severity: MODERATE
Onset: DELAYED
Hemorrhoids Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Yeast Infection Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Scaly And Itchy Rashes Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Drowsiness Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
Angioedema Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Hair Loss Incidence:
<5.0%*
Severity: MILD
Onset: DELAYED
Inability To Sleep Incidence:
<6.0%*
Severity: MILD
Onset: EARLY
Distressed Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
Acne Incidence:
<15.0%*
Severity: MILD
Onset: DELAYED
Fluid Retention Incidence:
1.0-3.0%*
Severity: MODERATE
Onset: DELAYED
Flushing Incidence:
1.0-4.9%*
Severity: MILD
Onset: RAPID
Itching Incidence:
1.0-3.0%*
Severity: MILD
Onset: RAPID
Excessive Mucle Tone Incidence:
1.0-3.0%*
Severity: MODERATE
Onset: DELAYED
Constipation Incidence:
1.0-5.0%*
Severity: MODERATE
Onset: DELAYED
Pus In Urine Incidence:
>1.0%*
Severity: MODERATE
Onset: DELAYED
Decreased Appetite Incidence:
1.0-2.9%*
Severity: MILD
Onset: DELAYED
Anemia Incidence:
>1.0%*
Severity: MODERATE
Onset: DELAYED
Weight Gain Incidence:
1.0-5.0%*
Severity: MILD
Onset: DELAYED
Vomiting Incidence:
1.0-6.0%*
Severity: MILD
Onset: EARLY
Muscle Pain Incidence:
1.0-4.9%*
Severity: MILD
Onset: EARLY
Migraine Incidence:
1.0-3.0%*
Severity: MODERATE
Onset: EARLY
Stomach Pain Incidence:
1.0-10.0%*
Severity: MILD
Onset: EARLY
Low Potassium Levels Incidence:
1.0-4.9%*
Severity: MODERATE
Onset: DELAYED
Blood In The Urine Incidence:
>1.0%*
Severity: MODERATE
Onset: DELAYED
High White Blood Cells Incidence:
1.0-4.9%*
Severity: MILD
Onset: DELAYED
Eye Infection Incidence:
1.0-2.9%*
Severity: MODERATE
Onset: DELAYED
Hirsutism Incidence:
1.0-5.0%*
Severity: MILD
Onset: DELAYED
Tired Incidence:
1.0-8.0%*
Severity: MILD
Onset: EARLY
Bruise Incidence:
1.0-3.0%*
Severity: MILD
Onset: DELAYED
Upset Stomach Incidence:
1.8-13.0%*
Severity: MILD
Onset: EARLY
Infection Incidence:
2.0-5.0%*
Severity: MILD
Onset: DELAYED
Fever Incidence:
>2.0%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
2.0-10.0%*
Severity: MILD
Onset: EARLY
Rhinitis Incidence:
2.1-12.0%*
Severity: MILD
Onset: EARLY
Headache Incidence:
3.0-37.0%*
Severity: MILD
Onset: EARLY
Back Pain Incidence:
>3.0%*
Severity: MILD
Onset: DELAYED
Upset Stomach Incidence:
6.0%*
Severity: MILD
Onset: EARLY
Gas Incidence:
6.0-8.0%*
Severity: MILD
Onset: EARLY
Lightheadedness Incidence:
7.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Budesonide 3mg Capsule

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Major Lifestyle Interaction
Grapefruit juice and Budesonide 3mg Capsule(Budesonide)
Grapefruit juice and Budesonide(Budesonide)
Grapefruit juice can increase the amount of oral Budesonide (Entocort-EC) that your body absorbs. Grapefruit juice and grapefruit-containing foods may increase the side effects of oral Budesonide. If possible, you should avoid grapefruit or grapefruit juice while taking Entocort-EC. At the very least, avoid large changes (i.e., either increases or decreases) in your daily intake of grapefruit and grapefruit juice. Grapefruit juice is not expected to interact significantly with inhaled or nasal Budesonide (Pulmicort or Rhinocort).
Pregnancy & Lactation Information
Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Budesonide

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.